140 related articles for article (PubMed ID: 18549640)
1. Antibody based conditioning for allogeneic hematopoietic stem cell transplantation.
Saha A; Blazar BR
Front Immunol; 2022; 13():1031334. PubMed ID: 36341432
[TBL] [Abstract][Full Text] [Related]
2. New allogeneic hematopoietic stem cell transplantation method: hematopoietic stem cell transplantation plus thymus transplantation for intractable diseases.
Hosaka N
Clin Dev Immunol; 2013; 2013():545621. PubMed ID: 23762092
[TBL] [Abstract][Full Text] [Related]
3. The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation.
Khuat LT; Dave M; Murphy WJ
Gut Microbes; 2021; 13(1):1966262. PubMed ID: 34455917
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two reduced intensity conditioning regimens: Flu-Bu2 versus RIC-TBF in allogeneic hematopoietic stem cell transplantation.
Verstraete E; Baumann C; Rousseau H; Campidelli A; Rubio MT; D'Aveni M
Leuk Lymphoma; 2024 Feb; 65(2):283-286. PubMed ID: 37990507
[No Abstract] [Full Text] [Related]
5. Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: introduction.
Wayne AS; Giralt S; Kröger N; Bishop MR
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1534-6. PubMed ID: 24035783
[TBL] [Abstract][Full Text] [Related]
6. Emerging concepts in haematopoietic cell transplantation.
Li HW; Sykes M
Nat Rev Immunol; 2012 May; 12(6):403-16. PubMed ID: 22627859
[TBL] [Abstract][Full Text] [Related]
7. A new step toward non-genotoxic conditioning prior to hematopoietic stem cell transplantation.
Cavazzana M; Calvo C
Mol Ther; 2024 Jun; 32(6):1604-1605. PubMed ID: 38776908
[No Abstract] [Full Text] [Related]
8. Curating evidence for a cure of HIV-1 infection by hematopoietic stem cell transplantation.
Bone B; Lichterfeld M
Med; 2023 May; 4(5):285-287. PubMed ID: 37178680
[TBL] [Abstract][Full Text] [Related]
9. Successful allogeneic stem cell transplantation with a reduced-intensity conditioning in a case of leukocyte adhesion deficiency type III.
Barhoom D; Behfar M; Mohseni R; Hamidieh AA
Hematol Transfus Cell Ther; 2024; 46(3):300-302. PubMed ID: 35256330
[No Abstract] [Full Text] [Related]
10. [Mycophenolate mofetil in treatment of graft-versus-host disease after allogeneic hematopoietic cell transplantation: analysis of 44 cases].
Chen H; Liu KY; Liu DH; Xu LP; Han W; Chen YH; Huang XJ
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2127-30. PubMed ID: 19080474
[TBL] [Abstract][Full Text] [Related]
11. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
Foss FM
Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic effect of allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens on hematological malignancies].
Yuan X; Sun ZM; Liu HL; Geng LQ; Wang ZY; Tong J; Yao W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):614-7. PubMed ID: 18549640
[TBL] [Abstract][Full Text] [Related]
13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
14. [Second allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and donor changes in relapsed hematological malignancies after the first allogeneic transplant].
Zhao YQ; Song YZ; Li ZH; Yang F; Xu T; Li FF; Yang DF; Wu T
Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):465-471. PubMed ID: 37550201
[No Abstract] [Full Text] [Related]
15. Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
Rodriguez R; Parker P; Nademanee A; Smith D; O'Donnell MR; Stein A; Snyder DS; Fung HC; Krishnan AY; Popplewell L; Cohen S; Somlo G; Angelopoulou M; Al-Kadhimi Z; Falk PM; Spielberger R; Kogut N; Sahebi F; Senitzer D; Slovak M; Schriber J; Forman SJ
Bone Marrow Transplant; 2004 Jun; 33(11):1123-9. PubMed ID: 15064696
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
